NCT01716208View on ClinicalTrials.gov

Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 14, 2013

Primary Completion Date

October 1, 2019

Study Completion Date

October 1, 2020

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

Ofatumumab + Fresh Frozen Plasma

Trial Locations (1)

95817

University of California Comprehensive Cancer Center, Sacramento

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Joseph Tuscano

OTHER

NCT01716208 - Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma | Biotech Hunter | Biotech Hunter